Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (8)	10/1/1996 6:46:00 PM
From: Boyce Burge	of 1494

I have no particular opinion about NTII, but want to know more since I follow neuroscience, and it is a Bay Area company. The Neuroinvestment letter (Harry Tracy) recently profiled NTII... He felt the co was reasonably valued at $6/share -- but he has a 12 month target of $12. The co. has competition from CNSI (they hace cerestat in phase III, well ahead of Memantine). ....and from Neurex and Interneuron in antistroke agents. To me it sounds like a roll of the dice, but NTII could get lucky. In my experience Tracy doesnt profile companies unless they have promise. , Check out Neuroinvestment... $295 per year but you can get a sample copy probably for free. Phone 603 964-9640 (As far as I know they have no website!!)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next